Of the spectrum of clinical and laboratory factors responsible for refractoriness to platelet transfusions, some are amenable to intervention, some to circumvention, and others only to acceptance and support for complications. Identification of the likely reason for refractoriness in a given individ
Diagnosis and treatment of patients refractory to platelet transfusions
β Scribed by M. Contreras
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 773 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0268-960X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We performed a retrospective review of patients with immuneβmediated thrombocytopenia (ITP) treated with prolonged infusions of intravenous immunoglobulin (IVIg) (1 g/kg by continuous infusion over 24 hr) and concurrent platelets (1 pheresis unit every 8 hr), to determine the response r
Fig. 1. a: Brain CT (May 6, 1996). Suprasellar lesion with involvement of diencephalic and chiasmatic regions and extensive peri-lesion edema. b: Brain CT after CdA therapy (May 24, 1996). Complete regression of the brain lesion.
## Abstract The aim of this study was to analyze the impact of various donor and machine parameters on PLT yield in 127 PLT apheresis procedures, to optimize PLT yield achieving clinical and economic advantages. One hundred and twentyβseven apheresis procedures were analyzed. Age, gender, volume pr